---
title: "TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290481558.md"
description: "TherapeuticsMD Inc. (TXMD) shares rose 2.56% to $2.00 on Monday, ending a two-day losing streak. However, the stock underperformed compared to competitors like AbbVie Inc., which gained 6.25%. Trading volume exceeded its 50-day average. Despite the daily gain, TXMD remains 32.20% below its 52-week high of $2.95 set in January."
datetime: "2026-06-22T21:31:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290481558.md)
  - [en](https://longbridge.com/en/news/290481558.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290481558.md)
---

# TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) rose 2.56% to $2.00 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.29% to 51,712.71 and the NASDAQ Composite Index falling 1.32% to 26,166.60.

The stock's rise snapped a two-day losing streak.

TherapeuticsMD Inc. closed 32.20% below its 52-week high of $2.95, which the company achieved on January 27th.

The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) rose 6.25% to $230.01.

Trading volume (42,438) eclipsed its 50-day average volume of 39,628.

Data source: Dow Jones Market Data, FactSet. Data compiled June 22, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-22-26 1731ET

### Related Stocks

- [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [TherapeuticsMD Q2 FY26 laba bersih turun ke US$ 164.000; revenue lisensi turun ke US$ 864.000](https://longbridge.com/en/news/295572651.md)
- [Synergy Asset Management LLC Grows Stock Position in AbbVie Inc. $ABBV](https://longbridge.com/en/news/296018925.md)
- [Cloudastructure Inc. reports Q2 results](https://longbridge.com/en/news/296127291.md)
- [Cornerstone Capital Inc. Takes Position in Cisco Systems, Inc. $CSCO](https://longbridge.com/en/news/295995972.md)
- [293,524 Shares in GFL Environmental Inc. $GFL Bought by S&CO Inc.](https://longbridge.com/en/news/296021664.md)